Leptin and Lipid Profile in Overweight Patient with Type 1 Diabetes

AIM: To evaluate leptin and lipid profile in overweight patients with type 1 diabetes.PATIENTS AND METHODS: The study included 50 overweight patients with type 1 diabetes and 50 age and sex matched healthy controls. Blood samples were taken for evaluation of glycosylated haemoglobin, lipid profile a...

Full description

Saved in:
Bibliographic Details
Published inOpen access Macedonian journal of medical sciences Vol. 5; no. 2; pp. 131 - 136
Main Authors Abd El Dayem, Soha M., Abd El Kader, Mona, Ibrahim, Soheir, Mokhtar, Enas, Abd El Megeed, Eman
Format Journal Article
LanguageEnglish
Published Macedonia ID Design 2012/DOOEL Skopje 15.04.2017
Subjects
Basic Science
type 1 diabetic patient
overweight
Leptin
lipid profile
Online AccessGet full text
ISSN1857-9655
1857-9655
DOI10.3889/oamjms.2017.033

Cover

Abstract AIM: To evaluate leptin and lipid profile in overweight patients with type 1 diabetes.PATIENTS AND METHODS: The study included 50 overweight patients with type 1 diabetes and 50 age and sex matched healthy controls. Blood samples were taken for evaluation of glycosylated haemoglobin, lipid profile and leptin. Also, urine samples were taken for evaluation of albumin/creatinine ratio.RESULTS: Leptin level was significantly lower in overweight with type 1 diabetes and showed a significant positive correlation with hip circumference and body mass index and negative correlation with glycosylated haemoglobin (HbA1c). Leptin level was significantly lower in overweight diabetic patients with HbA1c > 7.5 %. The best cut-off point between overweight diabetic group and control group regarding leptin levels was found at 16.9 (ng/ml) with a sensitivity of 68% and specificity of 56%, area under the curve 0.623.CONCLUSION: Leptin levels were found to be low in overweight patients with type 1 diabetes and showed correlation with the body mass index and hip circumference. LDL was significantly higher while HDL was significantly lower in the diabetic, overweight group indicating increased risk of cardiovascular disease. Leptin level in overweight diabetic patients might be related to the metabolic control.
AbstractList To evaluate leptin and lipid profile in overweight patients with type 1 diabetes.AIMTo evaluate leptin and lipid profile in overweight patients with type 1 diabetes.The study included 50 overweight patients with type 1 diabetes and 50 age and sex matched healthy controls. Blood samples were taken for evaluation of glycosylated haemoglobin, lipid profile and leptin. Also, urine samples were taken for evaluation of albumin/creatinine ratio.PATIENTS AND METHODSThe study included 50 overweight patients with type 1 diabetes and 50 age and sex matched healthy controls. Blood samples were taken for evaluation of glycosylated haemoglobin, lipid profile and leptin. Also, urine samples were taken for evaluation of albumin/creatinine ratio.Leptin level was significantly lower in overweight with type 1 diabetes and showed a significant positive correlation with hip circumference and body mass index and negative correlation with glycosylated haemoglobin (HbA1c). Leptin level was significantly lower in overweight diabetic patients with HbA1c > 7.5 %. The best cut-off point between overweight diabetic group and control group regarding leptin levels was found at 16.9 (ng/ml) with a sensitivity of 68% and specificity of 56%, area under the curve 0.623.RESULTSLeptin level was significantly lower in overweight with type 1 diabetes and showed a significant positive correlation with hip circumference and body mass index and negative correlation with glycosylated haemoglobin (HbA1c). Leptin level was significantly lower in overweight diabetic patients with HbA1c > 7.5 %. The best cut-off point between overweight diabetic group and control group regarding leptin levels was found at 16.9 (ng/ml) with a sensitivity of 68% and specificity of 56%, area under the curve 0.623.Leptin levels were found to be low in overweight patients with type 1 diabetes and showed correlation with the body mass index and hip circumference. LDL was significantly higher while HDL was significantly lower in the diabetic, overweight group indicating increased risk of cardiovascular disease. Leptin level in overweight diabetic patients might be related to the metabolic control.CONCLUSIONLeptin levels were found to be low in overweight patients with type 1 diabetes and showed correlation with the body mass index and hip circumference. LDL was significantly higher while HDL was significantly lower in the diabetic, overweight group indicating increased risk of cardiovascular disease. Leptin level in overweight diabetic patients might be related to the metabolic control.
To evaluate leptin and lipid profile in overweight patients with type 1 diabetes. The study included 50 overweight patients with type 1 diabetes and 50 age and sex matched healthy controls. Blood samples were taken for evaluation of glycosylated haemoglobin, lipid profile and leptin. Also, urine samples were taken for evaluation of albumin/creatinine ratio. Leptin level was significantly lower in overweight with type 1 diabetes and showed a significant positive correlation with hip circumference and body mass index and negative correlation with glycosylated haemoglobin (HbA1c). Leptin level was significantly lower in overweight diabetic patients with HbA1c > 7.5 %. The best cut-off point between overweight diabetic group and control group regarding leptin levels was found at 16.9 (ng/ml) with a sensitivity of 68% and specificity of 56%, area under the curve 0.623. Leptin levels were found to be low in overweight patients with type 1 diabetes and showed correlation with the body mass index and hip circumference. LDL was significantly higher while HDL was significantly lower in the diabetic, overweight group indicating increased risk of cardiovascular disease. Leptin level in overweight diabetic patients might be related to the metabolic control.
AIM: To evaluate leptin and lipid profile in overweight patients with type 1 diabetes.PATIENTS AND METHODS: The study included 50 overweight patients with type 1 diabetes and 50 age and sex matched healthy controls. Blood samples were taken for evaluation of glycosylated haemoglobin, lipid profile and leptin. Also, urine samples were taken for evaluation of albumin/creatinine ratio.RESULTS: Leptin level was significantly lower in overweight with type 1 diabetes and showed a significant positive correlation with hip circumference and body mass index and negative correlation with glycosylated haemoglobin (HbA1c). Leptin level was significantly lower in overweight diabetic patients with HbA1c > 7.5 %. The best cut-off point between overweight diabetic group and control group regarding leptin levels was found at 16.9 (ng/ml) with a sensitivity of 68% and specificity of 56%, area under the curve 0.623.CONCLUSION: Leptin levels were found to be low in overweight patients with type 1 diabetes and showed correlation with the body mass index and hip circumference. LDL was significantly higher while HDL was significantly lower in the diabetic, overweight group indicating increased risk of cardiovascular disease. Leptin level in overweight diabetic patients might be related to the metabolic control.
Author Abd El Dayem, Soha M.
Abd El Megeed, Eman
Ibrahim, Soheir
Mokhtar, Enas
Abd El Kader, Mona
AuthorAffiliation 4 Pediatrics Department, Cairo, Egypt
2 Clinical Pathology Department, National Research Centre, Cairo, Egypt
3 Pediatrics Department, Al-Azhar University, Cairo, Egypt
1 Pediatrics Department, National Research Centre, Cairo, Egypt
AuthorAffiliation_xml – name: 4 Pediatrics Department, Cairo, Egypt
– name: 3 Pediatrics Department, Al-Azhar University, Cairo, Egypt
– name: 1 Pediatrics Department, National Research Centre, Cairo, Egypt
– name: 2 Clinical Pathology Department, National Research Centre, Cairo, Egypt
Author_xml – sequence: 1
  givenname: Soha M.
  surname: Abd El Dayem
  fullname: Abd El Dayem, Soha M.
– sequence: 2
  givenname: Mona
  surname: Abd El Kader
  fullname: Abd El Kader, Mona
– sequence: 3
  givenname: Soheir
  surname: Ibrahim
  fullname: Ibrahim, Soheir
– sequence: 4
  givenname: Enas
  surname: Mokhtar
  fullname: Mokhtar, Enas
– sequence: 5
  givenname: Eman
  surname: Abd El Megeed
  fullname: Abd El Megeed, Eman
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28507616$$D View this record in MEDLINE/PubMed
BookMark eNp1UT1PwzAQtRCIQmFmQx5ZWuwkjp0FCZVPqVIZYLYuzoUaJXGI01b997hqqQCJ6U537737eKfksHENEnLB2ThWKrt2UH_UfhwxLscsjg_ICVdCjrJUiMMf-YCce__BGOMiS3kUHZNBpASTKU9PyGSKbW8bCk1Bp7a1BX3pXGkrpKE4W2K3Qvs-7-kL9Babnq5sP6ev6xYpp3cWcuzRn5GjEiqP57s4JG8P96-Tp9F09vg8uZ2OTCxVPCqYzKHIoUQQKROGJRwSJUuJyuR5gkqUYApQoFKT5oIZUyLKLCqlgiLNs3hIbra67SKvsTBhnw4q3Xa2hm6tHVj9u9PYuX53Sy2SKJwbBYGrnUDnPhfoe11bb7CqoEG38JqrLEtYlkgZoJc_Z-2HfH8uAK63ANM57zss9xDO9MYevbVHb-zRwZ7AEH8YxvbhrW6zrK3-5X0BGWSXXA
CitedBy_id crossref_primary_10_18229_kocatepetip_408118
crossref_primary_10_3389_fendo_2023_1235409
Cites_doi 10.18295/2075-0528.2623
10.1007/978-1-4615-7198-8_1
10.1016/j.jacl.2009.07.002
10.1016/j.jpeds.2006.04.064
10.1590/S0103-05822012000100010
10.1007/s00592-010-0214-4
10.1007/s00125-007-0921-8
10.1016/j.febslet.2004.11.024
10.2337/dc08-0277
10.1038/sj.ijo.0802484
10.2337/diacare.26.5.1356
10.1161/01.STR.0000053843.03997.35
10.1055/s-2007-984781
10.2337/diacare.29.02.06.dc05-0724
10.1530/eje.0.1390049
10.1016/j.jpeds.2004.06.042
10.1111/j.1520-037X.2006.4019.x
10.1001/jama.2009.2012
10.1210/jc.2009-1993
10.1111/j.1399-5448.2006.00216.x
10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L
10.1016/j.epag.2015.03.001
10.1016/j.jpeds.2006.10.054
10.1097/MED.0b013e3283073a5a
10.2337/dc08-1775
10.1007/s00125-005-0082-6
10.1053/meta.2002.30502
10.1056/NEJM198402093100605
10.1017/S0007114508055682
10.1530/eje.0.1510475
10.1056/NEJM197102182840703
10.1016/S0009-9120(00)00136-3
10.2174/1874216501106010110
10.1016/S0002-9149(02)02953-3
10.1016/j.diabres.2006.09.023
10.1007/s00125-005-1832-1
10.1530/eje.1.02261
10.1016/j.jpeds.2009.12.017
ContentType Journal Article
Copyright Copyright: © 2017 Soha M. Abd El Dayem, Mona Abd El Kader, Soheir Ibrahim, Enas Mokhtar, Eman Abd El Megeed. 2017
Copyright_xml – notice: Copyright: © 2017 Soha M. Abd El Dayem, Mona Abd El Kader, Soheir Ibrahim, Enas Mokhtar, Eman Abd El Megeed. 2017
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.3889/oamjms.2017.033
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1857-9655
EndPage 136
ExternalDocumentID PMC5420762
28507616
10_3889_oamjms_2017_033
Genre Journal Article
GroupedDBID 53G
AAYXX
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
CITATION
C~G
DYU
HYE
IPNFZ
KQ8
M48
M~E
OK1
PGMZT
RIG
RPM
SLJYH
GROUPED_DOAJ
NPM
7X8
ABFKT
5PM
ID FETCH-LOGICAL-c3783-d07badbafea5605c041a487f7e8cbb4e85facda8a86c6b50ccfee792f78ad6b93
IEDL.DBID M48
ISSN 1857-9655
IngestDate Thu Aug 21 13:39:14 EDT 2025
Fri Sep 05 12:42:05 EDT 2025
Thu Jan 02 22:26:57 EST 2025
Thu Apr 24 22:59:41 EDT 2025
Tue Jul 01 05:10:04 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Keywords type 1 diabetic patient
overweight
Leptin
lipid profile
Language English
License http://creativecommons.org/licenses/by-nc/4.0
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3783-d07badbafea5605c041a487f7e8cbb4e85facda8a86c6b50ccfee792f78ad6b93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3889/oamjms.2017.033
PMID 28507616
PQID 1899409477
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5420762
proquest_miscellaneous_1899409477
pubmed_primary_28507616
crossref_primary_10_3889_oamjms_2017_033
crossref_citationtrail_10_3889_oamjms_2017_033
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-04-15
PublicationDateYYYYMMDD 2017-04-15
PublicationDate_xml – month: 04
  year: 2017
  text: 2017-04-15
  day: 15
PublicationDecade 2010
PublicationPlace Macedonia
PublicationPlace_xml – name: Macedonia
– name: Republic of Macedonia
PublicationTitle Open access Macedonian journal of medical sciences
PublicationTitleAlternate Open Access Maced J Med Sci
PublicationYear 2017
Publisher ID Design 2012/DOOEL Skopje
Publisher_xml – name: ID Design 2012/DOOEL Skopje
References 30739
30741
30740
30747
30746
30749
30748
30743
30742
30745
30744
30729
30728
30730
30736
30735
30738
30737
30732
30731
30734
30733
30718
30717
30719
30725
30724
30727
30726
30721
30720
30723
30722
30750
30752
30751
30714
30758
30713
30757
30716
30715
30759
30710
30754
30753
30712
30756
30711
30755
16365724 - Diabetologia. 2006 Feb;49(2):298-305
9703378 - Eur J Endocrinol. 1998 Jul;139(1):49-53
16990661 - Eur J Endocrinol. 2006 Oct;155(4):609-14
6690964 - N Engl J Med. 1984 Feb 9;310(6):356-60
12716788 - Diabetes Care. 2003 May;26(5):1356-61
15971059 - Diabetologia. 2005 Aug;48(8):1445-53
18796620 - Diabetes Care. 2008 Dec;31(12):2338-43
14652620 - Int J Obes Relat Metab Disord. 2004 Jan;28(1):17-21
12459418 - Am J Cardiol. 2002 Nov 21;90(10C):3L-7L
15642335 - FEBS Lett. 2005 Jan 17;579(2):295-301
15476448 - Eur J Endocrinol. 2004 Oct;151(4):475-81
16939740 - J Pediatr. 2006 Sep;149(3):320-3
16603826 - Prev Cardiol. 2006 Spring;9(2):82-8
11963582 - J Pak Med Assoc. 2002 Jan;52(1):29-34
20371668 - J Clin Endocrinol Metab. 2010 Jun;95(6):2868-76
9868980 - Diabet Med. 1998 Dec;15(12):1045-51
17118479 - Diabetes Res Clin Pract. 2007 May;76(2):245-50
5539916 - N Engl J Med. 1971 Feb 18;284(7):353-7
16704858 - Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(1):25-30
21291823 - J Clin Lipidol. 2009 Aug;3(4):269-74
18755049 - Br J Nutr. 2009 Apr;101(8):1262-6
20706852 - Acta Diabetol. 2011 Mar;48(1):41-53
15480366 - J Pediatr. 2004 Oct;145(4):452-7
18196217 - Diabetologia. 2008 Apr;51(4):554-61
11887162 - Metabolism. 2002 Mar;51(3):292-6
20223481 - J Pediatr. 2010 Jun;156(6):923-9
11074239 - Clin Biochem. 2000 Aug;33(6):475-80
18594271 - Curr Opin Endocrinol Diabetes Obes. 2008 Aug;15(4):321-5
17236891 - J Pediatr. 2007 Feb;150(2):146-50, 150.e1-2
19092167 - Diabetes Care. 2009 Mar;32(3):416-20
12574553 - Stroke. 2003 Feb;34(2):418-21
21748132 - Sultan Qaboos Univ Med J. 2006 Dec;6(2):27-31
20071470 - JAMA. 2010 Jan 20;303(3):242-9
16443863 - Diabetes Care. 2006 Feb;29(2):218-25
References_xml – ident: 30727
  doi: 10.18295/2075-0528.2623
– ident: 30717
  doi: 10.1007/978-1-4615-7198-8_1
– ident: 30722
  doi: 10.1016/j.jacl.2009.07.002
– ident: 30740
  doi: 10.1016/j.jpeds.2006.04.064
– ident: 30759
  doi: 10.1590/S0103-05822012000100010
– ident: 30758
– ident: 30738
  doi: 10.1007/s00592-010-0214-4
– ident: 30716
– ident: 30733
  doi: 10.1007/s00125-007-0921-8
– ident: 30714
  doi: 10.1016/j.febslet.2004.11.024
– ident: 30712
  doi: 10.2337/dc08-0277
– ident: 30730
  doi: 10.1038/sj.ijo.0802484
– ident: 30755
  doi: 10.2337/diacare.26.5.1356
– ident: 30731
  doi: 10.1161/01.STR.0000053843.03997.35
– ident: 30746
  doi: 10.1055/s-2007-984781
– ident: 30753
  doi: 10.2337/diacare.29.02.06.dc05-0724
– ident: 30724
  doi: 10.1530/eje.0.1390049
– ident: 30756
  doi: 10.1016/j.jpeds.2004.06.042
– ident: 30754
  doi: 10.1111/j.1520-037X.2006.4019.x
– ident: 30711
  doi: 10.1001/jama.2009.2012
– ident: 30726
  doi: 10.1210/jc.2009-1993
– ident: 30739
  doi: 10.1111/j.1399-5448.2006.00216.x
– ident: 30744
  doi: 10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L
– ident: 30751
– ident: 30749
– ident: 30741
  doi: 10.1016/j.epag.2015.03.001
– ident: 30748
  doi: 10.1016/j.jpeds.2006.10.054
– ident: 30710
  doi: 10.1097/MED.0b013e3283073a5a
– ident: 30720
– ident: 30745
– ident: 30750
  doi: 10.2337/dc08-1775
– ident: 30735
  doi: 10.1007/s00125-005-0082-6
– ident: 30737
– ident: 30725
  doi: 10.1053/meta.2002.30502
– ident: 30719
  doi: 10.1056/NEJM198402093100605
– ident: 30752
– ident: 30729
  doi: 10.1017/S0007114508055682
– ident: 30713
  doi: 10.1530/eje.0.1510475
– ident: 30718
  doi: 10.1056/NEJM197102182840703
– ident: 30721
  doi: 10.1016/S0009-9120(00)00136-3
– ident: 30742
– ident: 30757
  doi: 10.2174/1874216501106010110
– ident: 30715
– ident: 30736
  doi: 10.1016/S0002-9149(02)02953-3
– ident: 30728
  doi: 10.1016/j.diabres.2006.09.023
– ident: 30732
  doi: 10.1007/s00125-005-1832-1
– ident: 30723
  doi: 10.1530/eje.1.02261
– ident: 30734
  doi: 10.1016/j.jpeds.2009.12.017
– ident: 30747
– ident: 30743
– reference: 15476448 - Eur J Endocrinol. 2004 Oct;151(4):475-81
– reference: 20223481 - J Pediatr. 2010 Jun;156(6):923-9
– reference: 21748132 - Sultan Qaboos Univ Med J. 2006 Dec;6(2):27-31
– reference: 16939740 - J Pediatr. 2006 Sep;149(3):320-3
– reference: 17236891 - J Pediatr. 2007 Feb;150(2):146-50, 150.e1-2
– reference: 11074239 - Clin Biochem. 2000 Aug;33(6):475-80
– reference: 18755049 - Br J Nutr. 2009 Apr;101(8):1262-6
– reference: 20071470 - JAMA. 2010 Jan 20;303(3):242-9
– reference: 16704858 - Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(1):25-30
– reference: 20371668 - J Clin Endocrinol Metab. 2010 Jun;95(6):2868-76
– reference: 9868980 - Diabet Med. 1998 Dec;15(12):1045-51
– reference: 12716788 - Diabetes Care. 2003 May;26(5):1356-61
– reference: 11963582 - J Pak Med Assoc. 2002 Jan;52(1):29-34
– reference: 18196217 - Diabetologia. 2008 Apr;51(4):554-61
– reference: 16990661 - Eur J Endocrinol. 2006 Oct;155(4):609-14
– reference: 16365724 - Diabetologia. 2006 Feb;49(2):298-305
– reference: 6690964 - N Engl J Med. 1984 Feb 9;310(6):356-60
– reference: 12459418 - Am J Cardiol. 2002 Nov 21;90(10C):3L-7L
– reference: 5539916 - N Engl J Med. 1971 Feb 18;284(7):353-7
– reference: 15971059 - Diabetologia. 2005 Aug;48(8):1445-53
– reference: 16603826 - Prev Cardiol. 2006 Spring;9(2):82-8
– reference: 11887162 - Metabolism. 2002 Mar;51(3):292-6
– reference: 14652620 - Int J Obes Relat Metab Disord. 2004 Jan;28(1):17-21
– reference: 20706852 - Acta Diabetol. 2011 Mar;48(1):41-53
– reference: 18594271 - Curr Opin Endocrinol Diabetes Obes. 2008 Aug;15(4):321-5
– reference: 16443863 - Diabetes Care. 2006 Feb;29(2):218-25
– reference: 18796620 - Diabetes Care. 2008 Dec;31(12):2338-43
– reference: 19092167 - Diabetes Care. 2009 Mar;32(3):416-20
– reference: 15480366 - J Pediatr. 2004 Oct;145(4):452-7
– reference: 12574553 - Stroke. 2003 Feb;34(2):418-21
– reference: 15642335 - FEBS Lett. 2005 Jan 17;579(2):295-301
– reference: 21291823 - J Clin Lipidol. 2009 Aug;3(4):269-74
– reference: 17118479 - Diabetes Res Clin Pract. 2007 May;76(2):245-50
– reference: 9703378 - Eur J Endocrinol. 1998 Jul;139(1):49-53
SSID ssj0001596122
Score 2.0119135
Snippet AIM: To evaluate leptin and lipid profile in overweight patients with type 1 diabetes.PATIENTS AND METHODS: The study included 50 overweight patients with type...
To evaluate leptin and lipid profile in overweight patients with type 1 diabetes. The study included 50 overweight patients with type 1 diabetes and 50 age and...
To evaluate leptin and lipid profile in overweight patients with type 1 diabetes.AIMTo evaluate leptin and lipid profile in overweight patients with type 1...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 131
SubjectTerms Basic Science
Title Leptin and Lipid Profile in Overweight Patient with Type 1 Diabetes
URI https://www.ncbi.nlm.nih.gov/pubmed/28507616
https://www.proquest.com/docview/1899409477
https://pubmed.ncbi.nlm.nih.gov/PMC5420762
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF60gngR39ZHWcGDl9Qmu9ndHESkWIpY7cFAPYV9BZU21T5A_707TVqt1ovXZCeEmQnzfbuTbxA6Vb6yxGiXvJQqj7JQe5EkxJOGuxzSjHMJ-5CtO9aM6U0n7HyNAyocOFxI7WCeVDzoVt_fPi7dB38BjFOI6Lwvey89kN72ebVGyDJacWWJARNrFVg__2U4ctU8yOV9FtmBLrAIgdez-SL1C3n-bKD8VpEaG2i9gJL4Ko_9Jlqy2RZabRWH5duofgsdKxmWmcEwotrgdj6gG7uL95OGaGDmuJ1Lq2LYksXAS7GPi0aZ4Q6KG9cP9aZXzEzwNOGCeKbGlTRKplY6LBPqGvWl4yQpt0IrRa0IU6mNFFIwzVRY0zq1lkdByoU0TEVkF5Wyfmb3EVZc0SgIlKYRoYRyZVPDqXYQRjIqrC6j6tRJiS4ExWGuRTdxxAIcnOQOTsDBiXNwGZ3NDF5zLY2_l55MvZ64fIdDDJnZ_niY-I4gAiflvIz28ijMHjYNXxnxufjMFoCW9vyd7Plpoqkd0sCZBgf_tjxEa_DycNDkh0eoNBqM7bHDKyNVcUj9Ma5MsvETCWPu7Q
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Leptin+and+Lipid+Profile+in+Overweight+Patient+with+Type+1+Diabetes&rft.jtitle=Open+access+Macedonian+journal+of+medical+sciences&rft.au=Dayem%2C+Soha+M.+Abd+El&rft.au=Kader%2C+Mona+Abd+El&rft.au=Ibrahim%2C+Soheir&rft.au=Mokhtar%2C+Enas&rft.date=2017-04-15&rft.pub=ID+Design+2012%2FDOOEL+Skopje&rft.eissn=1857-9655&rft.volume=5&rft.issue=2&rft.spage=131&rft.epage=136&rft_id=info:doi/10.3889%2Foamjms.2017.033&rft_id=info%3Apmid%2F28507616&rft.externalDocID=PMC5420762
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1857-9655&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1857-9655&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1857-9655&client=summon